283 related articles for article (PubMed ID: 34535993)
1. Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19.
Gori M; Ghirardi A; D'Elia E; Imeri G; Di Marco F; Gavazzi A; Carobbio A; Balestrieri G; Giammarresi A; Trevisan R; Amoroso M; Raimondi F; Novelli L; Magro B; Mangia G; Lorini FL; Fagiuoli S; Barbui T; Rizzi M; Cosentini R; Sironi S; Senni M;
Eur J Prev Cardiol; 2022 May; 29(5):e196-e199. PubMed ID: 34535993
[No Abstract] [Full Text] [Related]
2. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Edmonston DL; South AM; Sparks MA; Cohen JB
Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
[TBL] [Abstract][Full Text] [Related]
3. Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.
Furuhashi M; Moniwa N; Takizawa H; Ura N; Shimamoto K
Hypertens Res; 2020 Aug; 43(8):837-840. PubMed ID: 32433641
[No Abstract] [Full Text] [Related]
4. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
5. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
Dworakowska D; Grossman AB
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
[TBL] [Abstract][Full Text] [Related]
6. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
Kreutz R; Algharably EAE; Azizi M; Dobrowolski P; Guzik T; Januszewicz A; Persu A; Prejbisz A; Riemer TG; Wang JG; Burnier M
Cardiovasc Res; 2020 Aug; 116(10):1688-1699. PubMed ID: 32293003
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic.
Kow CS; Hasan SS
Expert Rev Cardiovasc Ther; 2021 Jan; 19(1):99-100. PubMed ID: 33112190
[No Abstract] [Full Text] [Related]
8. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
[No Abstract] [Full Text] [Related]
9. Hypertension and COVID-19: Current Evidence and Perspectives.
Gallo G; Calvez V; Savoia C
High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):115-123. PubMed ID: 35184271
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis.
Lee MMY; Docherty KF; Sattar N; Mehta N; Kalra A; Nowacki AS; Solomon SD; Vaduganathan M; Petrie MC; Jhund PS; McMurray JJV
Eur Heart J Cardiovasc Pharmacother; 2022 Feb; 8(2):165-178. PubMed ID: 33337478
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
[No Abstract] [Full Text] [Related]
12. SARS-CoV-2 and hypertension.
Ravichandran B; Grimm D; Krüger M; Kopp S; Infanger M; Wehland M
Physiol Rep; 2021 Jun; 9(11):e14800. PubMed ID: 34121359
[TBL] [Abstract][Full Text] [Related]
13. Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
Zhong Y; Zhao L; Wu G; Hu C; Wu C; Xu M; Dong H; Zhang Q; Wang G; Yu B; Lv J; Wu C; Zhang S; Cao C; Shu L; Pan Y; Liu X; Wu F
J Int Med Res; 2020 Dec; 48(12):300060520979151. PubMed ID: 33322988
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection.
Alfano G; Guaraldi G; Fontana F; Ferrari A; Magistroni R; Mussini C; Cappelli G;
Blood Purif; 2021; 50(2):263-267. PubMed ID: 32344395
[No Abstract] [Full Text] [Related]
15. Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Gnavi R; Demaria M; Picariello R; Dalmasso M; Ricceri F; Costa G
Clin Infect Dis; 2020 Nov; 71(16):2291-2293. PubMed ID: 32442294
[TBL] [Abstract][Full Text] [Related]
16. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension.
Lee J; Jo SJ; Cho Y; Lee JH; Oh IY; Park JJ; Cho YS; Choi DJ
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S123-S131. PubMed ID: 32872731
[TBL] [Abstract][Full Text] [Related]
18. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
19. RAAS inhibitors in COVID-19: They are not all the same!
Kow CS; Ramachandram DS; Hasan SS
Rev Port Cardiol; 2023 Sep; 42(9):815-816. PubMed ID: 37353197
[No Abstract] [Full Text] [Related]
20. Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations.
Palazzuoli A; Tecson KM; McCullough PA
J Hypertens; 2021 Aug; 39(8):1725-1726. PubMed ID: 34188007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
